Form 4: Illumina Director Scott Ullem Boosts Stake Through Stock Compensation

Illumina Director Scott B. Ullem acquired 307 shares of common stock valued at $81.1998 per share as part of his 2025 second-quarter board and committee retainer fees.

Summary

• Scott B. Ullem, a Director at Illumina, Inc. (ILMN), acquired 307 shares of the company's common stock.
• The transaction date for this acquisition was June 30, 2025.
• The shares were acquired at a price of $81.1998 per share.
• Following this transaction, Mr. Ullem directly beneficially owns 8,137 shares of Illumina common stock.
• The acquisition represents Mr. Ullem's election to receive 100% of his 2025 second-quarter board and committee cash retainer fees in Illumina stock.
• The number of shares issued was determined by dividing the cash compensation otherwise payable by the volume-weighted average closing price per share during the immediately completed quarter.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a director's decision to take stock compensation, indicating confidence and alignment with shareholder interests, although it's not a direct cash purchase.

Positives

• A Director's election to receive compensation in company stock demonstrates confidence in the company's future performance and aligns their interests with those of shareholders.
• The increase in direct beneficial ownership by a key insider signals a positive outlook from within the company's leadership.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4 filing, as it primarily reports a past transaction.

Industry Context

This specific insider transaction reflects an individual director's compensation choice and direct investment in Illumina, Inc. It does not directly provide broader industry trends or competitive insights, but it underscores a director's commitment to a leading company in the genomics and life sciences sector.

Related Party Transactions

• Director Scott B. Ullem elected to receive 100% of his 2025 board and committee cash retainer fees in Illumina stock, which constitutes a transaction between a company and a related party (a director).

Stakeholder Impact

• Shareholders may view this transaction positively as it demonstrates increased alignment between a director's personal financial interests and the company's stock performance, potentially fostering greater confidence in management's commitment to shareholder value.

Key Dates

Recommendation

Keywords

Illumina, ILMN, Scott B. Ullem, Director, Insider Transaction, Form 4, Stock Compensation, Share Acquisition, Corporate Governance, Biotechnology, Life Sciences